This market has settled: RESOLVED
Settled on March 25, 2026
Will there be at least 4000 measles cases in the U.S. in 2026?
Will there be at least 4000 measles cases in the U.S. in 2026? Odds: 71.0% YES on Polymarket. See live prices and trade this market.
Measles Cases in the U.S. in 2026: A Public Health Prediction Market
Current Odds
| Platform | Yes | No | Volume | Trade |
|---|---|---|---|---|
| Polymarket | 68.5% | 31.5% | $97K | Trade on Polymarket |
Market Analysis
The market is pricing in a nearly 7-in-10 chance of a measles outbreak exceeding 4,000 cases by year-end 2026, reflecting genuine concerns about declining vaccination rates and the erosion of herd immunity across multiple U.S. demographics. This matters now because vaccination policy will likely shift significantly depending on 2024-2025 political outcomes, and the baseline measles immunity in the U.S. population is already at historically low levels—setting conditions for rapid spread if triggered.
The bull case for 4,000+ cases rests on three concrete mechanisms: (1) the documented decline in MMR vaccination rates from 95% to 93.1% among kindergarteners as of 2023-2024, accelerating in pockets of vaccine-hesitant communities, (2) the potential for a Trump administration to weaken vaccine mandates or CDC authority (critical if Trump wins in November 2024), and (3) ongoing importation risk—the U.S. saw 58 measles cases in 2023 and 139 in 2024, and any international outbreak in 2025-2026 could spark sustained transmission in low-immunity pockets. Even minor outbreaks in school clusters can cascade rapidly when vaccination coverage drops below 90%.
The bear case hinges on competing dynamics: measles requires high transmissibility (R0 ~12-18) and low immunity, but most U.S. regions still maintain >85% coverage; outbreaks are highly visible, triggering rapid public health response and temporary vaccination upticks; and there’s inherent uncertainty about whether policy changes actually alter vaccination behavior at scale by 2026. Previous measles rebounds (2014-2015, 2019) stayed well below 1,500 cases despite lower vaccination rates, suggesting the 4,000 threshold is materially high.
Traders should monitor three specific triggers: (1) any legislative action on vaccine mandates in 2025 following potential Trump administration changes to OSHA/school requirements, (2) the extent and location of imported measles cases in late 2025, and (3) kindergarten vaccination rates announced in fall 2025 for the 2025-2026 school year—if they dip below 90% in any major metro area, transmission risk jumps sharply. The current 68.5% odds appear to be pricing in moderate policy headwinds rather than a catastrophic breakdown in vaccination infrastructure.
Related Markets
- Will the Iranian regime fall by April 30? — 8% YES
- Will Claude 5 be released by March 31, 2026? — 4% YES
- Will Albania win Eurovision 2026? — 0% YES
Frequently Asked Questions
What vaccination rate would realistically trigger 4,000+ measles cases?
A sustained drop below 85% immunity in urban or suburban regions, combined with a significant imported case cluster, would create conditions for rapid spread; this threshold is plausible but not yet locked in nationwide.
How much can a single measles import case in 2025-2026 actually affect this outcome?
A single case can seed outbreaks in low-immunity schools (under 90% vaccinated) leading to dozens of secondary cases; the 2019 outbreak started with imported cases and hit 1,282 cases, so importation is a key variable but 4,000 requires unusually high transmission duration.
If the Trump administration removes school vaccination mandates in 2025, when would we see measles cases spike measurably?
Mandate removal would take effect in fall 2025 (most school enrollment windows), with outbreak visibility likely in winter 2025-2026 if immunity drops sharply; full manifestation of the 4,